Cargando…
Fenretinide (4-HPR) Targets Caspase-9, ERK 1/2 and the Wnt3a/β-Catenin Pathway in Medulloblastoma Cells and Medulloblastoma Cell Spheroids
Medulloblastoma (MB), a neuroectodermal tumor arising in the cerebellum, represents the most frequent childhood brain malignancy. Current treatments for MB combine radiation and chemotherapy and are often associated with relevant side effects; novel therapeutic strategies are urgently needed. N-(4-H...
Autores principales: | Bassani, Barbara, Bartolini, Desirèe, Pagani, Arianna, Principi, Elisa, Zollo, Massimo, Noonan, Douglas M., Albini, Adriana, Bruno, Antonino |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4930187/ https://www.ncbi.nlm.nih.gov/pubmed/27367907 http://dx.doi.org/10.1371/journal.pone.0154111 |
Ejemplares similares
-
Electrotaxis of Glioblastoma and Medulloblastoma Spheroidal Aggregates
por: Lyon, Johnathan G., et al.
Publicado: (2019) -
Fenretinide (4-HPR): A Preventive Chance for Women at Genetic and Familial Risk?
por: Cazzaniga, Massimiliano, et al.
Publicado: (2012) -
Epigenetics and immune cells in medulloblastoma
por: Gorini, Francesca, et al.
Publicado: (2023) -
Convergence of BMI1 and CHD7 on ERK Signaling in Medulloblastoma
por: Badodi, Sara, et al.
Publicado: (2017) -
Combination of BMI1 and MAPK/ERK inhibitors is effective in medulloblastoma
por: Badodi, Sara, et al.
Publicado: (2022)